Mind Medicine (MindMed) Inc reports results for the quarter ended in June - Earnings Summary
13/08/2024 14:51
* Mind Medicine (MindMed) Inc MNMD.OQ reported a quarterly
adjusted loss of 5 cents per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -76 cents. The mean expectation of
nine analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -46 cents
to -27 cents per share.
* Reported revenue was zero; analysts expected zero.
* Mind Medicine (MindMed) Inc's reported EPS for the quarter
was a
loss of 8 cents.
* The company reported a quarterly loss of $5.85 million.
* Mind Medicine (MindMed) Inc shares had fallen by 5.0% this
quarter and gained 87.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Mind Medicine
(MindMed) Inc is $21.00
This summary was machine generated from LSEG data August 13 at
01:51 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.33 -0.05 Beat
Mar. 31 2024 -0.53 -1.14 Missed
Dec. 31 2023 -0.46 -0.59 Missed
Sep. 30 2023 -0.67 -0.45 Beat